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Abstract
Mathematical models that integrate multi-scale physiological data can offer insight into physiological and pathophysi-
ological function, and may eventually assist in individualized predictive medicine. We present a methodology for
performing systematic analyses of multi-parameter interactions in such complex, multi-scale models. Human physiology
models are often based on or inspired by Arthur Guyton’s whole-body circulatory regulation model. Despite the significance
of this model, it has not been the subject of a systematic and comprehensive sensitivity study. Therefore, we use this model
as a case study for our methodology. Our analysis of the Guyton model reveals how the multitude of model parameters
combine to affect the model dynamics, and how interesting combinations of parameters may be identified. It also includes
a ‘‘virtual population’’ from which ‘‘virtual individuals’’ can be chosen, on the basis of exhibiting conditions similar to those
of a real-world patient. This lays the groundwork for using the Guyton model for in silico exploration of pathophysiological
states and treatment strategies. The results presented here illustrate several potential uses for the entire dataset of
sensitivity results and the ‘‘virtual individuals’’ that we have generated, which are included in the supplementary material.
More generally, the presented methodology is applicable to modern, more complex multi-scale physiological models.
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Introduction
Global initiatives such as the IUPS Physiome project [1,2] and
the Virtual Physiological Human (VPH) project [3,4] aim to
quantitatively understand human physiology at all levels from gene
to organism through the use of mathematical modelling. Beyond a
certain degree of complexity, the combinatorial number of
interactions between the parts of a system can defy intuition and
present severe challenges [5]. Mathematical models are appropri-
ate tools for developing our understanding of human physiology,
since they can be used to represent and analyse the combinatorial
number of interactions between parameters in a rigorous and
systematic manner [6].
In short, computational models that integrate physiological data
from multiple scales (both physical and temporal) provide a
framework for understanding the maintenance of biological
entities under physiological and pathological conditions. One
significant application for such models is individualized predictive
medicine; i. e., tailoring models to the characteristics of an
individual patient and predicting the outcomes of different
treatment strategies, to help select the best strategy for that patient
[3].
Many challenges must be overcome before a truly integrative
model of human physiology can be constructed [6,7]. Gaining a
real quantitative understanding of the phenotypic variation in
humans as a function of genes and environment in a mechanistic
sense (i. e., understanding the genotype-phenotype map in both
the explanatory and predictive sense [8–10]) is a tremendous
challenge that awaits technological, conceptual and methodolog-
ical breakthroughs [11].
A number of models have already been used to develop insight
into aspects of human physiology [12–22], many of which have
their origin in the control-theory model of whole-body circulatory
regulation introduced by Guyton et al. in 1972 [23,24]. Although
it was published over 30 years ago, the Guyton model remains a
landmark achievement, and with the rise in the last 10 years of
systems physiology, it has attracted renewed attention [18,25–27]
and even generated some recent controversy [24,28–30]. It was
PLoS Computational Biology | www.ploscompbiol.org 1 June 2012 | Volume 8 | Issue 6 | e1002571the first ‘‘whole-body’’, integrated mathematical model of a
physiological system; it was particularly instrumental in identifying
and exploring the relationship between blood pressure and sodium
balance, and in demonstrating the key role of the kidney in long-
term regulation of blood pressure. It allows for the dynamic
simulation of systemic circulation, arterial pressure, and body fluid
regulation, including short- and long-term regulations.
In previous work, the Guyton models were modularized and re-
implemented in Fortran, C++ (M2SL [31]), and Simulink [14].
Furthermore, since one of the main limitations of the early Guyton
models is the low-resolution description of most of their
constituting modules, a framework was built to allow replacement
of the original sub-modules by new versions at a higher temporal
or spatial resolution [32]; e. g., a pulsatile heart was introduced to
treat systolic and diastolic blood pressures instead of only mean
blood pressure [33], and a detailed model of the renin-angiotensin-
aldosterone system (RAAS) has also been integrated [34]. That
work was also linked to efforts in the European VPH via two
Exemplar Projects, one of which used our modular reimplementa-
tion of the Guyton model as the basic set of ‘‘bricks’’ for a
collaborative core-modeling environment for multi-organ physiol-
ogy modeling [13,14], and the other uses the Guyton model as a
demonstrator for the tagging of parameters and variables with a
set of reference ontologies common to databases of high-
throughput genomic and proteomic data [35]. Collaborators in
the Physiome/VPH community have also carried out XML
markup of the individual modules of the Guyton model in CellML
(http://models.cellml.org/workspace/guyton_2008), thus provid-
ing precious documentation of its structure and content.
The analysis and results presented here arose naturally from this
body of work. Our motivation was to develop a methodology for
systematically exploring the ramified implications of multi-
parameter interactions in multi-scale physiological models. We
present such a methodology, which incorporates the elementary
effects technique introduced by Morris [36]. As a case study, we
present a sensitivity analysis of the 1992 version of the Guyton
model [24,30,37], with a focus on the multiple interactions
involved in blood pressure regulation. This version was never
published, but represents a more complete and modern under-
standing of the cardiovascular system [24,30] (e. g., the inclusion
of ANP [37]), and it is the version that members of the Guyton
group have continued to use. Indeed, such a model, grounded in
decades of hands-on experimental work and built with an
engineer’s approach to control processes, should serve as a
rigourous platform for discovery of non-intuitively obvious
relationships. However, despite the significance of the Guyton
model, the dynamics of the model have not yet been analysed in a
systematic and comprehensive study.
The results provide valuable information about the inter-
dependencies of parameter effects on the model outputs, thus
providing direction for future physiologically-applicable sensitivity
studies of the effects of changes to multiple parameters. These
results also lay the groundwork for the use of multi-parameter
models such as the Guyton model in systematic in silico exploration
of possible new drug effects, hypotheses about multiple perturba-
tions leading to disease states, and alternative treatment strategies.
An additional outcome is the production of a virtual population,
where each virtual individual is characterized by its set of parameter
values (loosely analogous to genotypes) and the associated outputs
(‘‘phenotypes’’). Note that the parameters of the Guyton model are
in fact lower-level phenotypes, but as models continue to span
larger physical and temporal scales, model parameters will
approach the genotype level [38,39]. A given real-world patient
can be associated with one or more of these virtual individuals on
the basis of clinically identifiable parameters or dynamics (e. g.,
mean arterial pressure, serum total protein, cardiac output, heart
rate). Searching an existing collection of simulations in this
manner avoids the inherent pitfalls in solving the inverse problem
of (uniquely) identifying unknown model parameters and states
from clinical observations [40]. Thus, the construction of a
comprehensive virtual population could prove a useful tool in
future efforts to provide efficient, individualized health-care.
Note that beyond the methodology itself, the results presented in
this manuscript also serve to demonstrate some of the uses to
which the complete set of elementary effects and virtual individuals
may be applied. We provide tables of all of the resulting output in
the supplementary material (Dataset S1), which we hope will be of
use in physiological, pathophysiological and clinical settings.
Methods
Elementary effects
The Guyton model comprises 219 parameters and 359 output
variables. We restricted our analysis to 96 parameters {x1 ...x96}
and 276 output variables {y1 ...y276} (as indicated in Equation 1,
Table 1, and documented in Tables S1 and S2), focusing on those
parameters with direct physiological relevance and ignoring
parameters with no clear physiological interpretation (such as
curve-fitting coefficients). The distribution of these 96 parameters
was: 32 cardiac, 21 renal, 16 autoregulation, 16 hormonal, 11
local circulation, and 4 thirst-related. To determine which
parameters have significant effects on each of the model outputs,
we computed the elementary effects of each parameter using a
modification of the formula defined by Morris [36], which we now
detail.
The influence dij of the parameter xi on some output yj is
defined by Equation 2. Assuming that each parameter xi is
normalized to the unit interval that ½0,1 , the region of
experimentation––the portion of the parameter space that will
be explored––is a regular n-dimensional p-level grid v, where each
Author Summary
As our understanding of the human body at all scales
increases, the construction of a ‘‘Virtual Physiological
Human’’ is becoming more feasible and will be an
important step towards individualized diagnosis and
treatment. As computational models increase in complex-
ity to reflect this growth in understanding, analysis of
these models becomes ever more complex. We present a
methodology for systematically analysing the interactions
between parameters and outputs of such complicated
models, using the Guyton model of circulatory regulation
as a case study. This model remains a landmark achieve-
ment that contributed to the development of our current
understanding of blood pressure control, and we present
the first comprehensive sensitivity analysis of this model.
Effects of varying each parameter are explored over
randomized simulations; our analysis demonstrates how
to use these results to infer relationships between model
parameters and the predicted physiological behaviour.
Understanding these relationships is of the utmost
importance for developing an optimal treatment strategy
for individual patients. These results provide new insight
into the multi-level interactions in the cardiovascular-renal
system and will be useful to researchers wishing to use the
model in pathophysiological or pharmacological settings.
This methodology is applicable to current and future
physiological models of arbitrary complexity.
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parameter xd in turn, a perturbation D~
n
p
is chosen (Equation 4).
For positive perturbations xdzD, we restrict xd[vz
d,n (Equation 5),
and for negative perturbations xd{D, we restrict xd[v{
i,n
(Equation 6), so that (xd+D)[vd.
For any point ^ x x[v (where xd[vz
d,n or xd[v{
d,n), Morris defined
the elementary effect di(^ x x) of xi as per Equation 7. In our analysis of
the Guyton model, we chose to normalize the elementary effects
with respect to yj(^ x x) (Equation 8) rather than by D, which is always
a fixed percentage of the range of xi.
Each elementary effect was calculated r times, where each of the
r simulations was performed with randomized values for all
parameters xi, in order to obtain a representative sample of the
magnitude of the effect.
Given a set of values for a single elementary effect eeij,i ti s
important to note that the mean and variance of this set provide
different insights into the nature of the relationship between the
parameter xi and the output yj. The mean indicates the sensitivity
of yj to xi, while the variance indicates the influence of other parameters
on this relationship or the non-linearity of the effect.
Monte Carlo simulations
For each random input vector ^ x x, a simulation was started with
the default initial state (^ y y0) and progressed for four weeks of
simulation (t~T1), at which time a pseudo-steady state had either
been reached, or a new random input vector ^ x x0 was chosen and
the simulation was restarted.
The parameter under investigation (xd) was then incremented
(or decremented) by D and the simulation continued for another
four weeks of simulation time, after which either a new pseudo-
steady state had been reached, or a new random input vector ^ x x0
was generated and the simulation was restarted.
Throughout the simulations, a number of output variables were
monitored to ensure that they remained within physiological
bounds (i. e., that the virtual individuals remained ‘‘alive’’, see
Table 2). If these bounds were violated during a simulation, the
simulation was discarded and a new input vector ^ x x was chosen.
Since the system is highly non-linear, the effects of a
perturbation in the parameter xd on the output variables ^ y y vary
over time, so elementary effects were calculated at times t[TEE
(Equation 9) and the state of the model (^ y y) was recorded at times
t[TR (Equation 10). The parameters for this mass-simulation
process are given in Table 3.
This entailed r|2|k~192000 simulations to obtain 2000
estimates (1000 with positive perturbations and 1000 with negative
perturbations) of the elementary effect of each parameter on each
output. In each simulation, two distinct points in parameter space
(^ x x before and after the perturbation) resulted in two steady states.
Each input vector and steady state can be viewed as a virtual
individual; that is, a virtual human whose ‘‘genotype’’ is described
by the input vector and whose ‘‘phenotype’’ is described by the
resulting steady-state outputs. Thus, the sensitivity analysis
simulations also produced a virtual population of 384,000 virtual
individuals. We detail how this virtual population may be of use
for diagnosis and exploration of treatment strategies for real-world
patients in our discussion.
Results
The results presented here are intended as a demonstration of the
analyses that are possible with the complete set of simulation results,
which are given in the supplementary material, namely: means and
deviations of each elementary effect at each time t[TEE;c o r r e l a t i o n s
between each parameter and each variable at each time t[TEE and
at time t~4 weeks (steady-state) for both the normotensive and
hypertensive sub-populations; and correlations between each
elementary effect and each variable at all times t[TEE.
The distribution of mean arterial pressure (MAP) in the virtual
population is shown in Figure 1. Given the Common Terminology
Criteria for Adverse Events v4.03 (CTCAE) [41] definition of
Stage 1 hypertension (systolic BP 140–159 mmHg or diastolic BP
90–99 mmHg) and the formula for estimating mean arterial
pressure from systolic and diastolic pressures (MAP&
2
3
DPz
1
3
SP [42]), we define hypertensive individuals as those with
Table 1. Equations for calculating elementary effects.
^ y y= f(^ x x); ^ y y:(y1, ..., y276); ^ x x:(x1, ..., x96) (1)
dij(^ x x)= dyj
dxi
(2)
vi =
f0,
1
p
,...,
p{1
p
,1g
(3)
D= n
p (4)
vz
i,n = f0,
1
p
,...,
p{n
p
g : xi[vz
i,n[(xizD)[vi
(5)
v{
i,n =
f
n
p
,
nz1
p
,...,1g : xi[v{
i,n[(xi{D)[vi
(6)
di(^ x x)= f(x1’, ..., xizD, ...x96
0){f(^ x x)
D
(7)
eeij(^ x x)= yj(..., xizD, ...){yj(^ x x)
yj(^ x x)
|
xi
D
(8)
doi:10.1371/journal.pcbi.1002571.t001
Table 2. The conditions on various model parameters that
were used to ensure that the virtual person remained ‘‘alive’’
during a simulation, based on definitions from the Common
Terminology Criteria for Adverse Events v4.03 (CTCAE) [41].
Parameter Minimum Maximum Unit
GFR 0.015 – L/min
CNA 120 160 mEq/L
CKE 2.5 8 mEq/L
HM 24 80 –
MAP 50 200 mmHg
HR 20 200 min{1
doi:10.1371/journal.pcbi.1002571.t002
Table 3. Parameters for building the virtual population.
TEE = fT1z1 minute, T1z1 hour, T1z1 day,
T1z1 week, T1z4 weeksg
(9)
TR = fT1g|TEE (10)
p= 50 (11)
D= 5
p
~0:1
(12)
r= 1000 (13)
k= 96 (14)
doi:10.1371/journal.pcbi.1002571.t003
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individuals were normotensive and two-thirds were hypertensive
(see Table 4; using an older definition of hypertension (160/95)
leads to 41% of virtual individuals being classified as hypertensive).
These proportions differ by less than 0:25% in the pre-
perturbation and post-perturbation steady states, and near-
identical proportions were also observed in earlier sets of
simulations (not presented here). This demonstrates that the
prevalence of hypertension in the virtual population is robust and
not dependent on the choice of random input vectors ^ x x.
Also shown in Figure 1 are gamma and chi-squared distribu-
tions that have been fitted to the probability density. The chi-
square distribution is a special case of the gamma distribution
where the scale parameter is 2. While the distributions provide
reasonable fits, they both underestimate the density for
MAP[½85,100  mmHg and overestimate the density for
MAP[½106,120  mmHg.
The analysis of the 192000 simulations investigated several
aspects of the resulting data. First, we present the sensitivity analysis
of the elementary effects on key output variables. The purpose was
to determine which parameters induced consistent effects when
perturbed, and how these effects are influenced by other
parameters. Second, the correlations between parameters and key
variables were considered, to identify relationships between the
outputs and fixed parameter values. Note that while the elementary
effects are shown to vary over time, the correlations remained
essentially constant. These correlations were then compared across
the normotensive and hypertensive sub-populations, to detect any
differences in these relationships between these two populations.
Finally, several generalized linear models (GLMs) [43,44] were
evaluated for their predictive power of identifying hypertensive
individuals based on a select number of parameters.
Definitions of all model 96 parameters and 276 variables are
tabulated Tables S1 and S2. More complete results are tabulated
in Dataset S1.
Sensitivity analysis
Given our interest in the development of hypertension, we focus
the discussion here on variables directly related to blood pressure.
For example, Figure 2a shows the most significant elementary
effects (at each time t[TEE) on three such variables: the mean
arterial pressure (MAP), the cardiac output (QAO), and the rate of
urine production (VUD).
The single largest effect on all three variables is that of HYL (the
quantity of interstitial hyaluronic acid), which affects the tissue
hydrostatic and osmotic pressures. This effect is only observed one
hour after the perturbation is made. That is, a change in hyaluronic
acid takes more than one minute to have an effect, and the effect is
no longer evident after 24 hours. The large deviations (signifi-
cantly larger than those of any other parameter) demonstrate that
the effects of HYL are highly non-linear. We will demonstrate how
to identify interesting multi-parameter effects, using HYL as an
example. To clearly depict the other elementary effects, they are
shown in Figure 2b without the effects of HYL. The largest steady-
state elementary effects at t~4 weeks are shown in Figure 3. The
complete table of elementary effects is available in the supple-
mentary material.
Effects on mean arterial pressure (MAP). Consider the
elementary effects on MAP at time t~1 minute. The only
appreciable effect is that of HSL (the basic strength of the left
ventricle). This (comparatively small) effect is not accompanied by
an effect of HSR (the basic strength of the right ventricle). The
effect of HSL at times tw1 minute were negligible.
At time t~1 hour, AARK (the basic resistance of the afferent
arteriole) has an effect on MAP, as do ANCSNS (sensitivity
controller, general angiotensin effect), ANUM (sensitivity control-
ler, angiotensin effect on arterial resistance and venous volume),
ANY (sensitivity controller, angiotensin effect on venous volume),
CPR (the critical plasma protein concentration for protein
destruction), EARK (the basic resistance of the efferent arteriole),
GFLC (glomerular filtration coefficient) and VV9 (basic venous
volume).
Some of these effects wane over time (ANCSNS, ANUM, ANY
and VV9), while the remaining effects become stronger over time
(AARK, CPR, EARK, GFLC) and exhibit the largest steady-state
elementary effects on MAP. Other parameters also exhibit
significant elementary effects over the longer timescales: HM6
(erythropoietic limiter), LPPR (rate of liver protein production),
NID (rate of sodium intake) and RNAUGN (basal renal
autoregulation feedback multiplier).
Thus, as the model approaches the steady-state following a
perturbation, the effects of hormones such as angiotensin are
reduced, whilst properties that directly affect glomerular filtration
exhibit the largest elementary effects. As one would expect, an
increase in AARK or a decrease in EARK (in isolation) results in a
permanent increase in the mean arterial pressure, due to a
decreased filtration rate. A decrease in glomerular permeability
(GFLC) produces a similar change for the same reason. The other
Figure 1. Probability density of mean arterial pressure (MAP) in
the virtual population. The vertical line marks the threshold of
hypertension (MAP§106:6 mmHg), and both gamma and chi-squared
distributions have been fitted.
doi:10.1371/journal.pcbi.1002571.g001
Table 4. Categorization of the virtual individuals into
normotensive and hypertensive populations, based on mean
arterial pressure (MAP).
Population Criteria Size Fraction
Normotensive MAPv106:6 mmHg 135,263 35%
Hypertensive MAP$106:6 mmHg 248,737 65%
doi:10.1371/journal.pcbi.1002571.t004
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ANMAM (sensitivity of afferent arterioles to angiotensin),
ANPXAF (sensitivity of afferent arteriole resistance to ANP),
CPR, HM6 and LPPR. The first three parameters affect
vasoconstriction in general (ANCSNS) and in the afferent arteriole
(ANMAM, ANPXAF), while the latter three affect the plasma
protein concentration and hematocrit (CPR, HM6, LPPR) and
thus affect the driving pressure gradient for glomerular filtration.
Note that the elementary effects of these parameters are not
evident until 1 day or 1 week after the original perturbation. These
observations reflect the infinite gain of the kidney in long-term
regulation of arterial blood pressure [45,46], as originally proposed
by Guyton [23].
Effects on cardiac output (QAO). The only observable
effects on QAO at time t~1 minute are from HSL and RVSM
(basal systemic venous resistance multiplier). As was shown for the
elementary effects on MAP, HSL exerts a short-term elementary
effect on QAO, and there is no elementary effect from HSR.
A number of parameters exhibit significant effects at time
t~1 hour that do not persist over longer timescales: ANY, PCR
(critical capillary pressure for protein leakage), RVSM and VV9.
Other parameters begin to exhibit elementary effects on QAO at
Figure 2. The most significant elementary effects on three key output variables at each time t[TEE.A :The effects on mean arterial
pressure (MAP), cardiac output (QAO) and rate of urine production (VUD) are plotted (at t~1 minute,1 hour,1 day,1 weekand 4 weeks after the
perturbations) as m+s. B: The most significant elementary effects when HYL is ignored. The complete tables of elementary effects are included in the
supplementary material.
doi:10.1371/journal.pcbi.1002571.g002
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AARK, ANUM, CPR, EARK, GFLC, NID, O2M (basic O2
utilization in non-muscle tissue) and OMM (basic O2 utilization in
muscle tissue, at rest). The most significant permanent effect on
QAO is exerted by HM6, the magnitude of which greatly
increases from t~1 day to t~1 week to t~4 weeks.
The major long-term effects on cardiac output (DeeijD§0:005)
govern: plasma protein concentration and hematocrit (CPR,
LPPR, HM6), the effect of angiotensin on arterial resistance and
venous volume (ANUM), glomerular filtration (AARK, EARK,
GFLC), sodium intake (NID) and O2 utilization (O2M, OMM).
The nature of the steady-state effects on QAO differ from those
on MAP. Several parameters cause permanent changes in both
QAO and MAP, but with smaller effects on QAO: AARK
(&25%), CPR (&50%) and GFLC (&67%). Conversely, pertur-
bations in EARK and NID have larger long-term effects on QAO
than on MAP (&150% and &400%, respectively). One param-
eter, HM6, exerts contrary effects on MAP and QAO; an increase
in HM6 causes an increase in arterial pressure but decreases the
cardiac output with an effect approximately 267% greater than the
effect on MAP. An increase in oxygen utilization in either muscle
or non-muscle tissue (OMM or O2M) results in a raised cardiac
output to increase the oxygen supply, but does not exert an
elementary effect on the mean arterial pressure. However, an
increase in the rate of protein production in the liver (LPPR) exerts
near-identical effects on the long-term mean arterial pressure and
the cardiac output.
Effects on urine production (VUD). The elementary effects
on VUD at time t~1 minute are from: AARK, ANCSNS, ANY,
EARK, GFLC, RNAUGN, RVSM, ANMAM, ANMEM (sensi-
tivity of efferent arterioles to angiotensin) and ANPXAF. Of these
parameters, the effects of AARK, ANCSNS, EARK, GFLC and
RNAUGN greatly diminish over time, and the effects of ANY,
RVSM, ANMAM, ANMEM and ANPXAF effectively disappear
by the time the model has reached the steady-state (t~4 weeks).
This is consistent with experimental observations that urine
production is rapidly altered in response to these perturbations
[47–49] and serves to maintain the arterial pressure [45,50], but
that the bulk of the change is transient (see Figure 3). This response
is mediated, at least in part, by activity of the renal sympathetic
nerves [51,52].
Several parameters that exhibited no elementary effect at
t~1 minute c a nb es e e nt oe x e r ta ne f f e c ta tt~1 hour:A N U M ,
AUTOSN (sensitivity controller, overall non-muscle vascular
resistance autoregulation), CPR, NID, POR (the reference value of
capillaryPO2 innon-muscletissue) andVV9.The effectsofANUM,
AUTOSN and VV9 wane over longer timescales (VV9 exerts no
effect at all by the steady-state), but the effects of CPR, NID and
POR are persistent. Note that the initial effect of CPR is positive
(t~1 hour), but that the effect is reversed at all subsequent times.
By time t~1 day, the elementary effects of all parameters have
essentially converged to their steady-state values. The major long-
term effects on urine production (DeeijD§0:01) are exerted by
parameters that have direct control over the glomerular filtration
(AARK, EARK, GFLC), the effects of angiotensin (ANCSNS,
ANUM), plasma protein concentration (CPR), sodium and
potassium intake (KID, NID) and non-muscle capillary PO2
(POR, which affects vasoconstriction over short, intermediate and
long-term timescales).
The nature of the steady-state effects on VUD (t~4 weeks)
differ from those on both QAO and MAP. As can be seen in
Figure 3, typically the elementary effects on VUD are significantly
larger than the effects on QAO and MAP, with much larger
deviations (i. e., interactions with other parameters). The same can
be said of QAO in comparison to MAP. That is, urine production
is more sensitive to perturbations than cardiac output, which in
turn is more sensitive to perturbations than arterial pressure. This
reflects Guyton’s explanation that the kidney acts as a servo-
controller of long-term blood pressure by adjusting salt and fluid
balance [53–56].
Figure 3. The largest elementary effects on three key output variables at t~1 hour and t~4 weeks. The effects on mean arterial pressure
(MAP), cardiac output (QAO) and rate of urine production (VUD) are plotted as m+s. Elementary effects were sorted by the magnitude of their largest
effect on the three output variables. A: The elementary effects at t~1 hour (excluding HYL). B: The elementary effects at t~4 weeks.
doi:10.1371/journal.pcbi.1002571.g003
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effects on NOD (sodium excretion, not shown here) were found
to be near-identical to those on VUD (urine production) at all
times t[TEE. The only elementary effects that differed appreciably
(by w5%) were those of KID (potassium intake), which had no
effect on sodium excretion, and NID (sodium intake), which had a
67% larger elementary effect on sodium excretion than on urine
production.
Multi-parameter effects: accounting for the variance in
HYL. We now demonstrate how the results of the sensitivity
analysis can be used to determine which parameters influence an
elementary effect. These are the parameters that are most likely to
be of interest when investigating the effects of multi-parameter
perturbations. By identifying such parameters with this method,
the number of multi-parameter combinations under consideration
can be greatly reduced, somewhat mitigating the combinatorial
growth in parameters combinations as the number of model
parameters increases. This information is of particular use when
trying to regulate some physiological function (e. g., pharmaco-
logical applications).
As illustrated in Figures 2a and 2b, the parameter HYL exerts
the greatest elementary effect on MAP, QAO and VUD at time
t~1 hour. The variance of this effect is also several times larger
than that of any other elementary effect, which indicates that
many other parameters interact with HYL and influence this
elementary effect.
The correlations and partial correlations (controlling for HYL)
between the variables (MAP, QAO and VUD) and the model
parameters differ by less than 0:2% (not shown). That is,
accounting for the value of HYL does not appreciably change
the correlations between the variables and the other parameters.
However, analysing the correlations between the elementary effect of
HYL and the remaining 95 parameters (Figure 4) reveals that, for
all three elementary effects of HYL, the most significant influence
is the parameter PCR (the critical capillary pressure for protein
leakage). Other parameters that are significantly correlated with
the elementary effects include CFC (capillary filtration coefficient),
CPR and RVSM. Sodium intake (NID) is also significantly
correlated with the elementary effect of HYL on urine production.
The significant parameters that have been identified by this
correlation analysis are all related to vessel and interstitial oncotic
pressures, which explains the nature of their influence on the
elementary effect of HYL. Hyaluronic acid plays a large role in
determining the hydrostatic and oncotic pressure of the tissue gel
in the Guyton model, and this effect is a function of the amount of
hyaluronic acid (HYL) in the tissue and the interstitial fluid volume
(VTS).
This analysis also demonstrates that the Guyton model fails to
account for other physiological effects of hyaluronic acid, such as
its role in water and solute balance in the inner medulla [57–60].
Were this effect included in the Guyton model, one would have
expected a number of parameters governing renal function to be
in evidence in Figure 4.
A limitation of the sensitivity analysis presented here is that only
a single parameter was perturbed during each simulation.
However since, for each parameter, this was done with thousands
of randomized sets of values for all of the remaining parameters,
we demonstrate that the results of our analysis can inform the
selection of interesting/relevant multi-parameter perturbations,
greatly reducing the computational cost of exhaustively searching
all possible multi-parameter perturbations.
Summary of the elementary effects. Parameter interac-
tions, which are evidenced by large variances, are more prevalent
at the shortest time-scales (t~1 minute and t~1 hour) and in the
largest steady-state effects (t~4 weeks), especially for the elemen-
tary effects on urine production. The results also suggest that
perturbations typically exert larger effects on urine production
than on mean arterial pressure and cardiac output, since at all times
shown in Figure 2b the elementary effects on VUD are much
larger than the effects on MAP and QAO at any time. This has
been observed in animal experiments [46,55,61].
The parameters that demonstrated the largest elementary
effects on multiple output variables at the steady-state
(t~4 weeks) are: AARK, EARK and GLFC (renal filtration),
Figure 4. Significant correlations between model parameters and the elementary effects of HYL at t~1 hour. Correlations (pv0:01) are
shown for the elementary effect of HYL on mean arterial pressure (MAP), cardiac output (QAO) and rate of urine production (VUD).
doi:10.1371/journal.pcbi.1002571.g004
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Parameters that govern the effects of angiotensin (ANCSNS,
ANMAM, ANMSML, ANUM) exhibited smaller steady-state
effects. The remaining parameters with significant steady-state
effects are related to oxygen consumption (O2M, OMM), diet
(KID, NID), sensitivity of afferent arteriole resistance to ANP
(ANPXAF), general autoregulation (AUTOSN, RNAUGN),
capillary PO2 (POR) and protein production (LPPR).
A perturbation in any of these parameters changes the steady-
state variable values. The importance of these parameters reflects
the role of the kidney in long-term blood pressure autoregulation
in both the Guyton model and human physiology [45,46]. The
effects of the parameters related to angiotensin reflect the effects of
angiotensin levels on the renal function curve [54]. That the most
significant renal parameters identified here (AARK, EARK and
GFLC) are all directly related to filtration and not to tubular
secretion or reabsorption is consistent with the original predictions
of the Guyton model: ‘‘Under normal circumstances, renal factors
that determine the glomerular filtration rate at different levels of
arterial blood pressure are quantitatively more important for the
control of arterial blood pressure than are renal tubular
mechanisms’’ [53]. This also reflects an underlying limitation of
the Guyton model: the renal module is highly simplistic and
considers very few aspects of nephron function.
Correlations between parameters and variables
Correlations were calculated between each parameter and each
output variable at each time t[fT1g|TEE, using the Spearman
rank-correlation [62]. A rank-correlation method was chosen
because such methods are sensitive to any near-monotonic
relationship and do not assume that the data is normally
distributed. The correlations showed negligible variance
(v10{3) over these times, in contrast to the elementary effects
presented earlier. This is because the correlations are sensitive to
the absolute value of the parameter, while the elementary effects are
sensitive to the influence of a perturbation and not the absolute
value. Significant correlations are shown in Figure 5 for the same
three variables (MAP, QAO and VUD) whose elementary effects
were presented in Figure 2.
Consider the correlations with MAP; the most-highly correlated
parameters (DxDw0:15) are CPR, AARK, EARK, GFLC and
HM6, all of which also exhibit significant elementary effects on
MAP. As noted earlier, all of these parameters affect glomerular
filtration: AARK, EARK and GFLC are all related to physical
properties of the glomerulus, while CPR and HM6 affect the
driving pressure gradient for ultrafiltration.
In contrast, the parameters most-highly correlated with QAO
(DxDw0:15) are HM6, OMM, CPR, EARK, NID, O2M and
RTPPR (the effect of glomerular oncotic pressure on renal tissue
oncotic pressure). RTPPR was not seen to exert a significant
elementary effect on QAO, but it shows a higher correlation with
QAO than do AARK, ANUM, GFLC and LPPR, all of which
exerted significant steady-state effects on QAO. Three of these
parameters––HM6, OMM and O2M––are directly related to
oxygen supply and utilization in the body, whilst CPR and NID
affect both the plasma volume and renal filtration, EARK also
affects renal filtration, and RTPPR affects tubular reabsorption.
The parameters most-highly correlated with VUD (DxDw0:15)
are NID, CPR, RTPPR, POR, AARK and KID. As was the case
for QAO, RTPPR does not exert a significant elementary effect on
VUD, but demonstrates higher correlation with VUD than do
ANCSNS, ANUM, EARK and GFLC, all of which exhibit
significant steady-state effects on VUD. All of these parameters,
except for POR, are directly related to renal filtration and
reabsorption, while POR modulates the vasoconstrictor effect on
blood-flow autoregulation across rapid, intermediate and long-
term timescales.
One parameter, CPR, is notable for being highly correlated
with all three output variables MAP, QAO and VUD. In
particular, CPR has a correlation of 0:63 with MAP; the only
other correlation greater than 0:5 is that between HM6 and QAO
({0:50). This parameter is the critical plasma protein concentra-
Figure 5. Significant correlations between model parameters and three key output variables. Correlations are shown for mean arterial
pressure (MAP), cardiac output (QAO) and rate of urine production (VUD), where pv0:05 and DcorrDw0:05.
doi:10.1371/journal.pcbi.1002571.g005
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oncotic pressure in the vasculature. The direct effects of this
parameter include the rate of glomerular filtration and the rate of
capillary leakage. These observations demonstrate that the Guyton
model reflects the importance of renal filtration and colloid oncotic
pressure to overall haemodynamic regulation [45,46,54,55].
Normotensive vs hypertensive sub-populations
The virtual individuals were divided into normotensive and
hypertensive sub-populations based on their mean arterial
pressure, as illustrated in Table 4. The probability densities of
each parameter and variable were compared across these
populations, as were the correlations between the model param-
eters and the output variables. The probability densities revealed
observable differences between the populations (Figure 6), both in
the model parameters (e. g., CPR) and output variables (e. g.,
AAR). Note that the two probability densities shown here for CPR
are markedly more distinct than when CPR was classified based
on the elementary effect of HYL (not shown).
However, obvious differences were observed for very few
parameters, all of which had already been highlighted in the
sensitivity and correlation analyses.
Correlations between parameters and variables were then
compared between the two populations; some results are shown
in Figure 7. The colour-coded regions of each graph represent
different relationships between the correlations: green indicates a
decreased correlation in the hypertensives; blue indicates an
increased correlation in the hypertensives; and red indicates that
the correlation has switched sign between the two populations.
The correlations with MAP in the hypertensive population are
systematically larger than those in the normotensive population
(Figure 7a), which supports the notion that arterial pressure
regulation has been reduced in the hypertensive population.
However, the correlations with QAO show no such relationship
(Figure 7b) with the sole exception of EARK. This suggests that
the regulation of cardiac output has not been reduced in the
hypertensive population, and that a change in cardiac output is
neither a cause nor symptom of the hypertension that is observed
in the virtual population, which reflects Guyton’s explanation of
arterial hypertension being fundamentally a renal pathology
[23,24,56].
When correlations with blood volume are considered (Figure 7c),
the parameters with the largest increases in correlation (ANCSNS,
ANUM, ANY) are all related to the effects of angiotensin on
arterial resistance and venous volume. Parameters with decreased
correlation in the hypertensive population include NID, VV9 and
CV (venous compliance). The logical inference is that angiotensin
is playing a more significant role in regulating the blood volume in
the hypertensive individuals than in the normotensive individuals.
Angiotensin plays a role in the activation of the RAAS [56,63,64],
which increases salt and water retention in the kidney [65–67] and
raises the ‘‘set-point’’ arterial pressure that the kidney will
maintain [50], and these effects are incorporated into the Guyton
model. More recent studies have also revealed angiotensin’s roles
in hypertension via oxidative stress [68–70] and inflammatory
vascular injury [71,72], but these phenomena are not included in
the Guyton model.
The correlations with urine production (Figure 7d) reveal
changes in only a few parameters. The decreased correlation with
RTPPR indicates that glomerular oncotic pressure has a smaller
effect on tubular reabsorption in the hypertensive population. Of
the parameters with increased correlations, AARK and POR are
directly related to blood-flow autoregulation and vasoconstriction,
and CPR affects the plasma colloid oncotic pressure, which affects
the plasma volume and the driving pressure gradient for
glomerular filtration. This leads us to conclude that the urine
production in the hypertensive population is more sensitive to
blood-flow autoregulation and plasma colloid oncotic pressure.
Identifying hypertensive virtual individuals with GLMs
The large virtual population that has been assembled here
(n~384,000) can be used not just to analyse relationships between
Figure 6. Probability densities of model variables in the normotensive and hypertensive virtual sub-populations. Probability densities
are shown for AAR (the afferent arteriolar resistance), POR (the reference value of capillary O2 pressure in non-muscle tissue) and CPR (the critical
plasma protein concentration for protein destruction).
doi:10.1371/journal.pcbi.1002571.g006
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for predicting particular phenotypes in virtual individuals. Since
hypertension places a heavy burden on health-care systems around the
world, and blood pressure regulation is the chief focus of the Guyton
model, the most obvious phenotype to predict is hypertension.
The virtual population was divided in two: a randomly-chosen
training set 1% of the population size, and the remainder of the
population served as an evaluation set. A generalized linear model
(GLM) [43,44] with a binomial distribution function was fitted to
the training set to predict whether or not each individual was
hypertensive (i. e., MAP§106:6 mmHg). A minimal GLM was
then selected by step-wise reduction of the original GLM with
Akaike’s information criterion (AIC) [73], resulting in a 30-
parameter classifier.
This classifier was then evaluated on the evaluation set (i. e., the
rest of the virtual population), shown in Figure 8a, and
demonstrated a high degree of accuracy. The sensitivity of the
classifier to each of the 30 parameters is shown in Figure 8b. This
list of parameters closely resembles those parameters most-highly
correlated with mean arterial pressure (Figure 5).
But no matter how accurately this classifier can predict
hypertension in the virtual population, one should not conclude
Figure 7. Comparison of correlations between parameters and variables in the normotensive and hypertensive virtual sub-
populations. For a given variable, the correlations with each parameter are plotted against the x-axis for the normotensive population, and against
the y-axis for the hypertensive population (only correlations c : DcDw0:1 are shown). A: Mean arterial pressure (MAP). B: Cardiac output (QAO). C:
Blood volume (VB). D: Rate of urine production (VUD).
doi:10.1371/journal.pcbi.1002571.g007
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world patients. The classifier is a function of 30 model parameters,
many of which are not physiologically derived or measurable. In
order to feasibly use such a classifier with real-world patients, the
model parameters must be restricted to those that are readily
identifiable and measurable in human beings.
Of the parameters listed in Figure 8b, we assume that CPR and
LPPR can be estimated from blood tests and that the values of the
renal filtration parameters AARK, EARK and GFLC could
possibly be estimated from whole-body glomerular filtration rate
(GFR) (or, more invasively, from a biopsy). NID can be estimated
from the person’s diet. The resulting classifier (‘‘Renal+Liver’’ in
Figure 8a, coefficients given in Table 5) predicts hypertension on
the basis of these parameters (see Table 6) and suffers from a
modest loss of predictive power in comparison to the optimal
classifier. It can correctly identify 90% of the hypertensive virtual
individuals with a 16% false-positive rate, in comparison to the
optimal false-positive rate of 9%. Further restricting the param-
eters to either solely liver-related or kidney-related (Table 6)
significantly reduces the predictive power of the classifiers.
Discussion
Validity of the Guyton model
The Guyton model was constructed and refined over many
years, and has been validated against a large amount of
experimental data [23,24]. However, many simplifications were
necessary in order to permit simulated experiments under the
computational resources that were available at the time [24], and
the model does not incorporate recent advances in our under-
standing of the cardiovascular system. Thus, our results will tend
to highlight the underlying assumptions and limitations of the
Guyton model, rather than physiological phenomena. Indeed, one
of the goals of this study was to provide sufficient data (in the
supplementary material) to allow researchers to identify whether
the Guyton model is sufficiently detailed for specific physiological
applications. More recent models have incorporated greater levels
of detail for individual organs [12,74] or for the whole body
[16,19], and a comparison between the Guyton model and these
newer models can illustrate the suitability of the Guyton model for
clinical applications. Of course, the methodology we employed can
be applied to these modern, more detailed models.
Here we present a brief comparison of the Guyton model to the
human renal/body fluid model of Uttamsingh et al. [74], which
was validated against several sets of experimental data. The result
of ingestion of either hypotonic and hypertonic fluid in the Guyton
model (shown in Figure 9) produces similar effects on the urine
flow rate to that seen in the model of Uttamsingh et al. However,
in response to the infusion of hypertonic saline (0.91 g of sodium
chloride per kg of body weight, over a period of 65 minutes for a
‘‘normal human of 70 kg’’) urine flow in the Guyton model
increases at a slower rate, plateaus at a lower rate and eventually
returns to the baseline level, while urine flow in [74] plateaus at
twice the baseline and better matches the experimental data [75].
Larger variation between the two models is observed when
aldosterone is increased four-fold, in order to simulate the
administration of deoxycorticosterone acetate (DOCA), a miner-
alocorticoid with similar effects to those of aldosterone [74]. The
model of Uttamsingh et al. demonstrates gradual increases in
extra-cellular fluid volume (1 L) and mean arterial pressure
(10 mmHg), and a rapid drop in sodium excretion in response
to the elevated aldosterone level, followed by a slow rise to match
the rate of intake. The Guyton model, as shown in Figure 10,
produces different behaviour. The extra-cellular fluid volume rises
briefly and then gradually decreases until it is 0.1 L below the
baseline (Figure 10a) and mean arterial pressure rapidly rises by
Figure 8. Evaluation of linear classifiers for identifying hypertensive virtual individuals. Each classifier (binomial GLM) was fitted to a
random 1% sample of the virtual population and then evaluated on the remaining 99%. A: ROC curves for several classifiers; the optimal (30-
parameter) classifier has an area under curve (AUC) of 0:970, demonstrating high predictive power. The 6-parameter ‘‘Renal+Liver’’ classifier performs
nearly as well (AUC=0.948). B: The parameter sensitivity of the optimal classifier. The y-axis measures the variation in the prediction over the range of
values for each parameter.
doi:10.1371/journal.pcbi.1002571.g008
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(Figure 10b). Sodium excretion (Figure 10d) drops rapidly in the
first 2 hours, then rises rapidly and overshoots in the following
6 hours, before equilibrating after 24 hours have elapsed. The
Uttamsingh et al. model again matches the experimental data [76]
better than the Guyton model (e. g., it reproduces the ‘‘escape’’
phenomenon, where the rate of sodium excretion eventually rises
to match the increased rate of intake). However, the limited time-
resolution (at most one data point every 24 hours) makes a precise
comparison impossible. Indeed, with the exception of the extra-
cellular fluid volume, the behaviour of the Guyton model also
provides a reasonable fit to the data.
The differences highlighted here between the Guyton model
and the model of Uttamsingh et al. are certainly due in part to the
lower level of detail in the renal portion of the Guyton model, but
the Guyton model also includes a more complete cardiovascular
model, which would necessarily alter the dynamics produced in
response to a chronic increase in aldosterone load. Thus, these
observations may indicate a shortcoming in the Guyton model, but
further analysis is required before a definitive statement can be
made. These results highlight, however, the need to identify
portions of the Guyton model that must be refined to replicate
experimental data more recent than those used to originally
validate the model. We discuss refinement of the Guyton model in
the following section.
In our analysis we perturbed a single parameter in each
simulaton (although each parameter was perturbed 1000 times,
each simulation with a different set of randomly-selected
parameter values). Perturbation of multiple parameters would
yield a wealth of additional information, but without any guidance
the only recourse would be to exhaustively search every
combination of N parameters, for N perturbations. Instead, with
the results presented here one can select one parameter (Pi) for
perturbation and additionally perturb only those parameters that
are significantly correlated with the effect of Pi (as per our brief
example: ‘‘Multi-parameter effects: accounting for the variance in
HYL’’).
Application to individualized medicine
Given the population of virtual individuals that was presented
here, an obvious and desirable application is to draw comparisons
between subsets of this population and a given real-world patient.
That is, given some observations of a real-world patient, we can
select those virtual individuals who best match these observations
and see whether one can draw conclusions about the condition of
the real-world patient based on the long-term dynamics of the
selected virtual individuals.
Beyond using virtual populations merely as a reference for the
current and ongoing condition of real-world patients who receive no
intervention, ongoing refinements of the Guyton model may
ultimately support individualized health-care and individualized
medicine. The application of mathematical models to individual-
ized medicine would necessarily involve integrating detailed
models of physiology, pharmacokinetics and pharmacodynamics.
Current efforts on this front include the BIMBO project [77].
Development of chronic diseases such as cardiovascular disease
is a complex process that involves environmental and cultural
factors shared by the individuals living in the same geographical
area, as well as ageing, genetic and disease determinants. Hunter
et al. [3] have emphasized the need for diagnostic workflows on
the prediction of risk that integrates the influence of both
population and patient-specific information in support of tailored
interventions aiming at optimizing diagnosis and treatment
planning and monitoring.
Table 6. The parameters used to predict hypertension in the
reduced-parameter GLMs (‘‘Renal’’, ‘‘Liver’’ and ‘‘Renal+Liver’’).
Name Description Unit GLM
CPR plasma protein concentration for protein
destruction
g/L Liver
AARK basic afferent arteriolar resistance mmHg min/L Renal
EARK basic efferent arteriolar resistance mmHg min/L Renal
LPPR rate of liver protein production g/min Liver
GFLC glomerular filtration coefficient L/min/mmHg Renal
NID rate of sodium intake mEq/min Both
doi:10.1371/journal.pcbi.1002571.t006
Table 5. The coefficients of each classifier (GLM) presented in
Figure 8a.
Classifier
Parameter Optimal Renal+Liver Liver Renal
(intercept) 232.66 212.6066 25.3854 0.92989
A3K 1.073e-5
AARK 16.95 11.9073 4.63921
ALDMM 20.1565
AMCSNS 0.5476
AMNAM 0.2681
ANCSNS 2.312
ANMAM 2.599
ANMEM 21.069
ANMSLT 0.2056
ANPXAF 0.5081
ANUM 0.2067
AUMK1 1.836
AUTOSN 20.9326
CPR 0.3703 0.2589 0.1310
DIURET 0.1422
DTNAR 0.5744
EARK 27.800 25.7318 22.56488
GFLC 2307.4 2235.5629 2115.02363
HM6 3.451e-3
HSL 1.315
HSR 1.374
LPPR 26.90 18.9798 9.7504
NID 4.322 2.7301 20.2501 0.07619
PCR 2.188e-2
RNAUGN 21.645
RTPPR 20.1121
SR 20.3817
SRK2 3.059e-5
TENSTC 24.460
VV9 21.035
doi:10.1371/journal.pcbi.1002571.t005
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approach to estimate the public health impact, in terms of the
reduction in the number of cardiovascular deaths (CVD), of
administering blood pressure lowering drugs to a virtual popula-
tion of patients [77]. That virtual population [77] (distinct from
the virtual population presented here) reproduces the demograph-
ic composition as well as the cardiovascular risk factor profiles of a
country population, each virtual individual being characterized by
a number of features allowing estimation of CVD risk and
treatment efficacy. The individuals eligible for treatment could be
selected from their computed CVD risk over a fixed threshold and
by having blood pressure in excess of 140/90 mmHg. The authors
used a simplified approach where treatment effect was represented
by the relative risk, which was assumed to be constant over time
and among different individuals, to estimate the public health
impact of BP lowering drugs [77].
The work presented here illustrates the value of using
population information to predict the success of treatment
strategies, whilst also moving towards a more ambitious goal:
taking into account the individual genetic backgrounds and
pathophysiological profiles. This would contribute to the delivery
of individualized healthcare, by optimizing the impact of
treatments for both the individual patient and at the population
level. Future challenges include the development of more
sophisticated effect models [78], such that relative-risks and odds
ratios depend on individual characteristics which affect the
pharmacokinetic and/or pharmacodynamic parts of the model
[79]. Realization of these goals would represent a significant step
towards personalizing anti-hypertensive treatment.
The implications of pharmacogenetic parameters on drug
efficacy have been explored in the context of diuretic treatment
for blood pressure [80–82]. One candidate for the identification of
responders to thiazide diuretics is the polymorphic gene coding the
cytoskeleton protein a-adducin, whose mutant form has been
associated with an increased rate of sodium reabsorption [83,84],
elevated blood pressure [85,86], salt-sensitivity [87] and increased
risk of cardiovascular events [88]. The same associations first
documented in Caucasian populations [84,87] have not been
reported in all other populations, with contradictory evidence from
studies in Chinese, African American and Japanese populations
[89], suggesting the role of additional factors in mediating the
effects attributed to the a-adducin polymorphism. But before
rejecting the hypothesis of a pharmacogenetic effect of the a-
adducin variant, a number of epistatic interactions and environ-
mental influences contained in the virtual population character-
istics (e. g., different degrees of RAAS activation in response to salt
consumption) could be explored through physiological modeling.
With regard to the diagnosis and treatment of hypertension, a
practical model would predict the effects of the various diuretics
and other drugs that are commonly administered to ameliorate
hypertension. This would allow the model predictions to be
directly compared to clinical studies such as INDANA [90]. To
this end, refinements are being incorporated into the original
Guyton model [32] as part of the SAPHIR project [13], such as a
detailed model of the RAAS [34]. The culmination of these efforts
will result in a richly-detailed and more accurate model of renal
autoregulation being incorporated into the Guyton model,
providing a platform for pharmacological predictions that may
assist in the diagnosis and treatment of hypertension [77].
Conclusion
We have presented a sensitivity analysis of the Guyton model of
human physiology (1992 version), which examined the elementary
effects of each parameter over a range of timescales and the
correlations between model parameters and key output variables. We
also demonstrated how interesting multi-parameter combinations can
be identified, and how this can highlight shortcomings in the model.
A pool of 384,000 simulations with randomized parameters
(analagous to genetic variants) was generated for this analysis,
forming a diverse virtual population of 384,000 virtual individuals
Figure 9. The effects of ingestion of hypotonic and hypertonic solutions on urine flow. These simulations reproduced the conditions
shown in Figures 3 and 4 of Uttamsingh et al. [74], which include experimental from Baldes and Smirk [93] and Dean and McCance [75]. A: Urine flow
following ingestion of 1 L of water. B: Urine flow following ingestion of hypertonic saline (normalized wrt. the urine flow rate prior to ingestion).
doi:10.1371/journal.pcbi.1002571.g009
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characteristics of individual real-world patients. The population
was divided into normotensive and hypertensive sub-populations,
and a 6-parameter linear classifier was shown to have good
predictive power for identifying hypertensive virtual individuals,
based on parameters that are feasible to estimate in vivo.
Work is currently underway on comparing these results to real-
world patient data from clinical studies of the effect of Avastin on
hypertension in cancer patients [91,92]. About half of the patients
develop hypertension in response to Avastin, and are also the most
likely to experience a remission. The analysis will aim to identify
whether any of the elementary effects or correlations presented in
this manuscript are evident in real-world patients, and to evaluate
the use of the virtual population in selecting regions of the
parameter space of the Guyton model that correspond to the
characteristics of a real-world patient. This exploratory project is
at a preliminary stage and no results can be presented at this time.
The methodology we have presented here and applied to the
Guyton model is generic in that it can be applied to any
mathematical model of sufficient complexity. As physiological
models encompass larger and larger scales, both spatially and
temporally, this methodology should prove beneficial in elucidat-
ing the subtle interactions between model parameters in these
complex models.
Figure 10. The effects of aldosterone loading on the human body. This simulation reproduced the conditions shown in Figure 5 of
Uttamsingh et al. [74], which inclues experimental data from Davis and Howell [94] and Relman and Schwartz [76]. A: Extra-cellular fluid volume. B:
Mean arterial pressure. C: Serum aldosterone (normalized). D: Sodium excretion rate.
doi:10.1371/journal.pcbi.1002571.g010
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using the Guyton model to assist in providing individualized
predictive medicine, as per the goals of both the IUPS Physiome
and the Virtual Physiological Human projects.
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